Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB010 multiple-dose study in mild allergic asthma
2012-003570-77Phase 2Completed
- Sponsor
- sterna biologicals
- Start
- Sep 2012
- Modality
- Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of SB010 in allergic asthma (2 arms), sponsored by sterna biologicals. Started Sep 2012; status: completed.
02
Drugs
SB010
03
Conditions
allergic asthma
Beyond the preview
Go deeper on 2012-003570-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003570-77.